Comment
doi: 10.1016/s0140-6736(05)74181-7.
First-line antihypertensive therapy. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension
- PMID: 10981916
- DOI: 10.1016/s0140-6736(05)74181-7
Item in Clipboard
Comment
First-line antihypertensive therapy. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension
Lancet.
.
No abstract available
Comment on
-
Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Lancet. 2000 Mar 11;355(9207):863-4. doi: 10.1016/s0140-6736(00)00092-1. Lancet. 2000. PMID: 10752699 Clinical Trial. No abstract available.
Similar articles
-
[Doxazosin and heart failure: a clinical conclusion is wanted].Lakartidningen. 2003 Dec 18;100(51-52):4328. Lakartidningen. 2003. PMID: 14756102 Swedish. No abstract available.
-
[Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].Lakartidningen. 2004 Jan 15;101(3):228-9. Lakartidningen. 2004. PMID: 14763097 Swedish. No abstract available.
-
Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial.Cleve Clin J Med. 2000 Jun;67(6):429-33. doi: 10.3949/ccjm.67.6.429. Cleve Clin J Med. 2000. PMID: 10860225
-
Doxazosin and congestive heart failure.J Am Coll Cardiol. 2001 Nov 1;38(5):1295-6. doi: 10.1016/s0735-1097(01)01534-0. J Am Coll Cardiol. 2001. PMID: 11691497 Review.
-
Doxazosin in the current treatment of hypertension.Expert Opin Pharmacother. 2008 Mar;9(4):625-33. doi: 10.1517/14656566.9.4.625. Expert Opin Pharmacother. 2008. PMID: 18312163 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
